Guerreiro S - Search Results

1

Modelling Parkinson-like neurodegeneration via osmotic minipump delivery of MPTP and probenecid.

Alvarez-Fischer D, Guerreiro S, Hunot S, Saurini F, Marien M, Sokoloff P, Hirsch EC, Hartmann A, Michel PP. Alvarez-Fischer D, et al. Among authors: guerreiro s. J Neurochem. 2008 Nov;107(3):701-11. doi: 10.1111/j.1471-4159.2008.05651.x. Epub 2008 Sep 16. J Neurochem. 2008. PMID: 18761710 Free article.

2

Protection of midbrain dopaminergic neurons by the end-product of purine metabolism uric acid: potentiation by low-level depolarization.

Guerreiro S, Ponceau A, Toulorge D, Martin E, Alvarez-Fischer D, Hirsch EC, Michel PP. Guerreiro S, et al. J Neurochem. 2009 May;109(4):1118-28. doi: 10.1111/j.1471-4159.2009.06040.x. Epub 2009 Mar 19. J Neurochem. 2009. PMID: 19302482 Free article.

3

KATP channel blockade protects midbrain dopamine neurons by repressing a glia-to-neuron signaling cascade that ultimately disrupts mitochondrial calcium homeostasis.

Toulorge D, Guerreiro S, Hirsch EC, Michel PP. Toulorge D, et al. Among authors: guerreiro s. J Neurochem. 2010 Jul;114(2):553-64. doi: 10.1111/j.1471-4159.2010.06785.x. Epub 2010 Apr 29. J Neurochem. 2010. PMID: 20456014 Free article.

4

Probenecid potentiates MPTP/MPP+ toxicity by interference with cellular energy metabolism.

Alvarez-Fischer D, Noelker C, Grünewald A, Vulinović F, Guerreiro S, Fuchs J, Lu L, Lombès A, Hirsch EC, Oertel WH, Michel PP, Hartmann A. Alvarez-Fischer D, et al. Among authors: guerreiro s. J Neurochem. 2013 Dec;127(6):782-92. doi: 10.1111/jnc.12343. Epub 2013 Jul 8. J Neurochem. 2013. PMID: 23802648 Free article.

5

Role of activity-dependent mechanisms in the control of dopaminergic neuron survival.

Michel PP, Alvarez-Fischer D, Guerreiro S, Hild A, Hartmann A, Hirsch EC. Michel PP, et al. Among authors: guerreiro s. J Neurochem. 2007 Apr;101(2):289-97. doi: 10.1111/j.1471-4159.2006.04424.x. J Neurochem. 2007. PMID: 17402966 Free article. Review.

6

Paraxanthine, the primary metabolite of caffeine, provides protection against dopaminergic cell death via stimulation of ryanodine receptor channels.

Guerreiro S, Toulorge D, Hirsch E, Marien M, Sokoloff P, Michel PP. Guerreiro S, et al. Mol Pharmacol. 2008 Oct;74(4):980-9. doi: 10.1124/mol.108.048207. Epub 2008 Jul 11. Mol Pharmacol. 2008. PMID: 18621927

7

Specific needs of dopamine neurons for stimulation in order to survive: implication for Parkinson disease.

Michel PP, Toulorge D, Guerreiro S, Hirsch EC. Michel PP, et al. Among authors: guerreiro s. FASEB J. 2013 Sep;27(9):3414-23. doi: 10.1096/fj.12-220418. Epub 2013 May 22. FASEB J. 2013. PMID: 23699175 Review.

8

The sleep-modulating peptide orexin-B protects midbrain dopamine neurons from degeneration, alone or in cooperation with nicotine.

Guerreiro S, Florence C, Rousseau E, Hamadat S, Hirsch EC, Michel PP. Guerreiro S, et al. Mol Pharmacol. 2015;87(3):525-32. doi: 10.1124/mol.114.095703. Epub 2014 Dec 31. Mol Pharmacol. 2015. PMID: 25552485

9

Methylxanthines and ryanodine receptor channels.

Guerreiro S, Marien M, Michel PP. Guerreiro S, et al. Handb Exp Pharmacol. 2011;(200):135-50. doi: 10.1007/978-3-642-13443-2_5. Handb Exp Pharmacol. 2011. PMID: 20859795 Review.

10

Neuroprotection of midbrain dopamine neurons by nicotine is gated by cytoplasmic Ca2+.

Toulorge D, Guerreiro S, Hild A, Maskos U, Hirsch EC, Michel PP. Toulorge D, et al. Among authors: guerreiro s. FASEB J. 2011 Aug;25(8):2563-73. doi: 10.1096/fj.11-182824. Epub 2011 Apr 20. FASEB J. 2011. PMID: 21507900

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

126 results

Search Page

Filters